# PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study

> **NCT02250313** · — · TERMINATED · sponsor: **MDx Health** · enrollment: 600 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02250313
- **Lead sponsor:** MDx Health
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2014-09
- **Primary completion:** 2018-07
- **Final completion:** 2018-07
- **Target enrollment:** 600 (ACTUAL)
- **Why stopped:** Pending final analysis for termination
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02250313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02250313, "PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02250313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*